MACROGENICS, INC. Warrants Not Settleable in Cash, Fair Value Disclosure
MACROGENICS, INC. (MGNX) had Warrants Not Settleable in Cash, Fair Value Disclosure of $679.30 thousand as of 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Notes › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:WarrantsNotSettleableInCashFairValueDisclosure · last filed 2014-03-20
- 2013-09-30: Warrants Not Settleable in Cash, Fair Value Disclosure $679.30K.
- 2012-12-31: Warrants Not Settleable in Cash, Fair Value Disclosure $52.95K.
| Period end | Warrants Not Settleable in Cash, Fair Value Disclosure |
|---|---|
| 2013-09-30 | $679.30K 10-Q · filed 2013-11-12 |
| 2012-12-31 | $52.95K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |